Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 showing a high safety profile have been tested in clinical trials. Bet v 1 fragments, as well as a Bet v 1 trimer, induced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback